Michael Von Bergwelt Email and Phone Number
Our group has a great interest in the role of B cells in cancer and has established together with others that:B cells…1….present antigen, prime T cells and home to SLO2...can be activated and expanded longterm with stable purity and function 3...can be used to dissect anti tumor T cell responses & identify novel tumor antigens4...play a central role in proinflammatory conditions5…can be used in ACT to cure cancer & viral disease6.…are organized in intratumoral TLS and mediate tumor control 7…play a promoting role in ICB8…can be inhibitory cells and thus can function as targets in the TME9…mediate several effector functions e.g. direct cell death, adcc, acpp, cdc10…are master regulators of immunity OUR GOALS ARE:I. To develop B cell ACT & in vivo B cell engineering II. To understand role of B cells in TME and develop approaches to better diagnose and treat cancerTo this end we founded several academic consortia and TABBY THERAPEUTICS to bring forward our vision in an internationally powerful network and also ITOC (www.itoc.eu) as a leading exchange platform to promote cellular cancer immunotherapy.—————————————————As oncologists with expertise in immunology, critical care and infectious disease we have also founded:iCHOP (intensive Care of Hematology and Oncology Patients) and Nine-I (Caring for the Critically Ill Immunosuppressed Cancer Patients),two nationally|internationally leading consortia that conduct to research concerning and develop management strategies of critically ill cancer patients e.g. immune based therapies.___________________________However, basic, translational and clinical research alone will never meet the goal to fully prevent unnecessary cancer deaths . To this end we have joined forces with a great group of friends, dedicated people and leaders from fields of cancer medicine, science, biotech, medtech, big pharma , media, patient organizations, politics and other stakeholders in cancer care to found the think tank Vision Zero (www.vision-zero-oncology.de) as a national movement to join forces across society and do whatever it takes to prevent cancer deaths!!!
Ludwig-Maximilians-Universität München
View-
VorstandsmitgliedWalther-Siegentaler-Gesellschaft Nov 2024 - PresentKöln, Nordrhein-Westfalen, Deutschland
-
UniversitätsprofessorLudwig-Maximilians-Universität München Dec 2017 - PresentMetropolregion MünchenProfessor & Chair Department of Medicine IIIFA Innere Medizin, Hämatologie/OnkologieInternistische Intensivmedizin, Allgemeine Intensivmedizin (EDIC), Notfallmedizin, Infektiologie, Zelltherapie & Stammzelltransplantation, Genetische Beratung -
KlinikdirektorLmu Klinikum München Dec 2017 - PresentMetropolregion München -
StandortsprecherDkfz Deutsches Krebsforschungszentrum Dktk München Jun 2023 - PresentMetropolregion München
-
VorstandsmitgliedVision Zero Oncology Jun 2020 - PresentBerlin München -
VorstandsmitgliedImmunotherapy Of Cancer Itoc Mar 2019 - PresentWien, Österreich
-
KuratoriumsvorsitzenderLebensmut_Muc May 2022 - Present -
Co-FounderTabby Therapeutics Mar 2022 - PresentTel Aviv | Boston
-
Founding MemberNine-I (Intensive Care Of Critically Ill Immunosuppressed Patients) Jan 2016 - PresentParis, Île-De-France, Frankreich
-
Founding MemberIchop (Intensive Care Of Hematology/Oncology Patients) Dgiin & Dgho Jan 2015 - Present
-
Leitender ArztUniversitätsklinik Köln Jul 2002 - Nov 2017Köln, Nordrhein-Westfalen, DeutschlandLeitender Oberarzt, Personaloberarzt, Leiter Cologne Interventional Immunology,Co-Leiter KMT, Stv. Leiter Internistische Intensivmedizin
-
Visiting Research ScholarStanford University Sep 2009 - Nov 2009Palo Alto, Kalifornien, Vereinigte Staaten Von Amerika -
Forscher (Postdoktorand)Harvard Medical School Feb 1997 - Nov 2000Boston, Massachusetts, Vereinigte Staaten Von Amerika
Michael Von Bergwelt Education Details
-
Immunology -
Universite De Paris SudHumanbiologie -
Geschichte Politik Philosophie -
Ärztekammer NordrheinFa Innere Medizin, Hämatologie&Onkologie, Intensivmedizin, Infektiologie, Notfallmed., Genet. Ber. -
European Society Of Intensive Care MedicineEuropean Diploma Of Intensive Care -
Deutsche Arbeitsgemeinschaft Für Hämatopoetische Stammzelltransplantation Und Zelluläre TherapieZertifikat Hsct & Zelltherapie -
Deutschland & UsaKapitän Segelschiffe & Yachten In Der Weltweiten Fahrt (Shs/Traditionsschiffer)
Frequently Asked Questions about Michael Von Bergwelt
What company does Michael Von Bergwelt work for?
Michael Von Bergwelt works for Ludwig-Maximilians-Universität München
What is Michael Von Bergwelt's role at the current company?
Michael Von Bergwelt's current role is Professor & Chair Med Dept III(Heme-Onc, Hemost, Precis. Onc/TU Genetics/Mol Diag, CGT/SCT, I.D., Crit Care, Psyonc.) @ LMU & CCC-DKTK-BZKF Munich| Oncologist interested in 4I: Intervent Immunology-Intensive care-I.D..
What schools did Michael Von Bergwelt attend?
Michael Von Bergwelt attended Albert-Ludwigs-Universität Freiburg (Albert Ludwig University Of Freiburg), Carl Von Ossietzky Universität Oldenburg, Universite De Paris Sud, Fernuniversität In Hagen, Ärztekammer Nordrhein, European Society Of Intensive Care Medicine, Deutsche Arbeitsgemeinschaft Für Hämatopoetische Stammzelltransplantation Und Zelluläre Therapie, Deutschland & Usa.
Not the Michael Von Bergwelt you were looking for?
-
Michael Von Bergwelt
Immunooncology, Cellular Therapy, Oncological Intensive CareCologne Bonn Region
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial